Dual Diagnosis: Clinical Trials

6 trials for Dual Diagnosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 active not recruiting. 6 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Completed 5, Active not recruiting 1
Phase 12Completed 2

Follow Dual Diagnosis: new trials by email Literature Review of Dual Diagnosis trials Research Report on Dual Diagnosis

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use
Cannabidiol, Risperidone - Dual Diagnosis
Phase 2Active not recruitingLone Baandrup642021-06-012026-01-27
Risperidone and Desipramine in Alcohol Use and Schizophrenia
Risperidone + Desipramine - Schizophrenia, Alcoholism
Phase 2CompletedDartmouth-Hitchcock Medical Center122011-12-012018-03-23
Abstinence-Linked Money Management Multisite
ATM, Individual Drug Counseling - Dual Diagnosis, Cocaine Abuse
Phase 2CompletedYale University1082009-12-012020-03-30
Effectiveness of Self-Help for Dually-Diagnosed Persons - 1
Double Trouble in Recovery, Standard psychiatric day treatment - Dual Diagnosis, Substance-Related Disorders
Phase 1 / Phase 2CompletedNational Institute on Drug Abuse (NIDA)2292003-03-012017-01-12
Effectiveness of Advisor-Teller Money Manager
Advisor-Teller Money Management-Substance Abuse Counselling - Substance Abuse, Dual Diagnosis
Phase 1 / Phase 2CompletedUS Department of Veterans Affairs1202002-07-012015-04-07
Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment
Matching Symptom Severity to Service Intensity - Dual Diagnosis
Phase 2CompletedUS Department of Veterans Affairs2362015-04-07

Narrower conditions

Substance-Related Disorders (3)  ·  Alcoholism (1)  ·  Cocaine-Related Disorders (1)  ·  Marijuana Abuse (1)  ·  Mental Disorders (1)  ·  Psychotic Disorders (1)  ·  Schizophrenia (1)

Broader conditions

Chemically-Induced Disorders (5)  ·  Mental Disorders (4)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (2)  ·  Substance-Related Disorders (2)  ·  Alcohol-Related Disorders (1)

Interventions

Risperidone (2)  ·  Cannabidiol (1)  ·  Desipramine (1)  ·  Salvage Therapy (1)

Sponsors

US Department of Veterans Affairs (2)  ·  Dartmouth-Hitchcock Medical Center (1)  ·  Lone Baandrup (1)  ·  National Institute on Drug Abuse (NIDA) (1)  ·  Yale University (1)

Countries

United States (5)  ·  Denmark (1)

Top investigators

Alan I Green, MD (1)  ·  Christine Timko, PhD (1)  ·  Lone Baandrup, MD, PhD (1)  ·  Marc I Rosen, M.D. (1)  ·  Marc I. Rosen, MD (1)  ·  Stephen Magura, Ph.D. (1)

Results publications

PMID 10737825, PMID 11452841, PMID 12556596, PMID 12710369, PMID 12940684, PMID 14756196, PMID 15063915, PMID 15151360, PMID 16814015, PMID 18161644, PMID 18626300, PMID 34391393

NIH funding

2018 (1), R01DA012952 (1)